|
AARS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.21069999767943E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.62229999995023E-06 |
| Normal-vs-Stage2 |
3.560800E-01 |
| Normal-vs-Stage3 |
1.60100044332978E-10 |
| Normal-vs-Stage4 |
1.790280E-04 |
| Stage1-vs-Stage2 |
1.277420E-01 |
| Stage1-vs-Stage3 |
5.903300E-03 |
| Stage1-vs-Stage4 |
3.443400E-01 |
| Stage2-vs-Stage3 |
4.801100E-03 |
| Stage2-vs-Stage4 |
5.247700E-02 |
| Stage3-vs-Stage4 |
4.159400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.86180004325377E-09 |
| Normal-vs-AfricanAmerican |
1.014590E-04 |
| Normal-vs-Asian |
8.497600E-03 |
| Caucasian-vs-AfricanAmerican |
8.697800E-01 |
| Caucasian-vs-Asian |
3.694000E-01 |
| AfricanAmerican-vs-Asian |
4.265800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.72219999991808E-07 |
| Normal-vs-Female |
6.01650000042753E-07 |
| Male-vs-Female |
4.281800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.3553000000055E-06 |
| Normal-vs-Age(41-60Yrs) |
3.92020000017368E-07 |
| Normal-vs-Age(61-80Yrs) |
1.357680E-04 |
| Normal-vs-Age(81-100Yrs) |
2.239000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.260000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.649200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.758800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.964200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.808800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.215400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.0705999999986E-05 |
| Classical-VS-Follicular |
4.024100E-03 |
| Classical-VS-Other |
3.044600E-01 |
| Classical-VS-Normal |
1.47499999991751E-08 |
| Tall-VS-Follicular |
2.06900000021548E-07 |
| Tall-VS-Other |
8.404800E-01 |
| Tall-VS-Normal |
7.16093850883226E-14 |
| Follicular-VS-Other |
3.438700E-03 |
| Follicular-VS-Normal |
2.605000E-01 |
| Other-VS-Normal |
7.74210000000775E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.561100E-04 |
| Normal-vs-N1 |
1.50290000444642E-08 |
| N0-vs-N1 |
1.915300E-03 |
|
|
